ArticleArchives of medical science : AMS2024
Global, regional, and national burdens of rheumatoid arthritis in young adults from 1990 to 2019.
Article in Archives of medical science : AMS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Global burden and inequalities of rheumatoid arthritis in adults aged 15-49 years from 1990 to 2021 and projections to 2050: a cross-sectional analysis from Global Burden of Disease Study 2021.Clinical rheumatology · 2026Article
- Evaluation of the Association Between Carrageenan and Systemic Inflammation: Results From the National Health and Nutrition Examination Survey.Molecular nutrition & food research · 2026Article
- Causal Effects of Lifestyle and Dietary Factors on Rheumatoid Arthritis: An Integrated Analysis Combining Mendelian Randomization, Machine Learning, and Evaluation of Burden Dynamics and Health Inequality.Food science & nutrition · 2026Article
- Association of lipid-based insulin resistance indices with rheumatoid arthritis prevalence: a cross-sectional study from NHANES 2007-2018.Clinical rheumatology · 2026Article
- Cellular stress, cell death, and extracellular vesicles: redefining the therapeutic landscape of rheumatoid arthritis.Clinical rheumatology · 2026Review
- UPLC-Q-TOF/MS, network pharmacology, molecular docking, and experimental validation to explore the mechanisms of toad clothing on rheumatoid arthritis.Scientific reports · 2025Article
- HPV cancer burden by anatomical site, country, and region in 2022.Scientific reports · 2025Article
- Burden of rheumatoid arthritis in India from 1990 to 2021: insights from the Global Burden of Disease Database.Frontiers in medicine · 2025Article
- Global, regional, and national burdens of rheumatoid arthritis among people aged 60 years and older from 1990 to 2021: a trend analysis for the Global Burden of Disease Study 2021.Frontiers in public health · 2025Article
- Trends in rheumatoid arthritis burden in China and globally, 1990-2021: A longitudinal study based on the GBD database.PloS one · 2025Article
- The relationship between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and rheumatoid arthritis: a cross-sectional study.Frontiers in nutrition · 2025Article
- Unveiling health inequalities and frontier gaps in elderly-onset rheumatoid arthritis: evolving impact of smoking and future challenges.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Our aim was to analyze the regional and national levels of the global burden of rheumatoid arthritis (RA) among young adults (aged 15-49) in order to identify long-term trends. Material and methods: The data for this study were obtained from the Global Burden of Disease Study (GBD) 2019, which assessed 369 diseases and injuries as well as 87 risk factors in 204 countries and 21 regions. To evaluate a nation's level of development, a composite statistic called the socio-demographic index (SDI) was utilized. We analyzed the age-standardized incidence rate (ASIR) and disability-adjusted life years (DALY) related to RA in individuals in young adults. Additionally, we estimated the annual percentage changes (EAPCs) for the aforementioned parameters. Results: From 1990 to 2019, there was a positive trend in the ASIR of and age-standardized DALY rate due to RA in young adults. The high-SDI region experienced the highest ASIR and age-standardized DALY rates due to RA, with significant increases in these parameters during the same period (EAPC = 0.46 and 0.41, respectively). The region that witnessed the largest increase in the ASIR of RA in young adults was Andean Latin America (EAPC = 1.48), while Qatar had the largest increase among countries (EAPC = 2.30). Similarly, Andean Latin America recorded the largest increase in the age-standardized DALY rate due to RA (EAPC = 0.98), with Qatar having the largest increase among countries (EAPC = 2.01). Conclusions: From 1990 to 2019, there was a notable increase in both the age-standardized DALY rates and ASIRs associated with RA in young adults. This positive trend was particularly evident in high-SDI regions. However, it is worth noting that the impact of RA on young adults in low-income areas of Andean Latin America was also substantial.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.